DLDaoming Li

Daoming Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daoming Li has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Center-Aware Adversarial Autoencoder for Anomaly Detection

    by Daoming Li, Qinghua Tao, Jiahao Liu, Huangang Wang

    Anomaly detection based on subspace learning has attracted much attention, in which the compactness of subspace is commonly considered as the core concern. Most related studies directly optimize the distance from the subspace representation to the fixed center, and the influence of the anomaly level of each normal sample is not considered to adjust the normal concentrated areas. In such cases, it is difficult to isolate the normal areas from the anomaly ones by making the subspace compact. To this end, we propose a center-aware adversarial autoencoder (CA-AAE) method, which detects anomaly samples by acquiring more compact and discriminative subspace representations. To fully exploit the subspace information to improve the compactness, anomaly-level description and feature learning are novelly integrated herein by dividing the output space of the encoder into presubspace and postsubspace. In presubspace, the toward-center prior distribution is imposed by the adversarial learning mechanism, and the anomaly level of normal samples can be described from a probabilistic perspective. In postsubspace, a novel center-aware strategy is established to enhance the compactness of the postsubspace, which achieves adaptive adjustment of the normal areas by constructing a weighted center based on the anomaly level. Then, a flexible anomaly score function is constructed in the testing stage, in which both the toward-center loss and the reconstruction loss are combined to balance the information in the learned subspace and the original space. Compared to other related methods, the proposed CA-AAE shows the effectiveness and advantages in numerical experiments.


  • Simultaneous preparation of edible quality medium and high purity diacylglycerol by a novel combined approach

    by Daoming Li, Xiaorong Zhong, Muniba Faiza, Weifei Wang, Weishuai Lian, Ning Liu, Yonghua Wang


  • A Novel Process for the Synthesis of Highly Pure n-3 Polyunsaturated Fatty Acid (PUFA)-Enriched Triglycerides by Combined Transesterification and Ethanolysis

    by Daoming Li, Weifei Wang, Xiaoli Qin, Xingxing Li, Bo Yang, Yonghua Wang

    In this study, a novel two-step enzymatic reaction was developed for the synthesis of highly pure triacylglycerols (TAGs) with a high content of n-3 polyunsaturated fatty acids (PUFAs). Glyceride mixtures were primarily synthesized by Novozym 435-catalyzed transesterification of glycerol and DHA/EPA-rich ethyl esters (EEs), followed by removal of partial glycerides, for the first time, by immobilized mono- and diacylglycerol lipase SMG1-F278N-catalyzed ethanolysis. TAG yield as high as 98.66% was achieved under the optimized conditions, and highly pure (98.75%) n-3 PUFA-enriched TAGs with 88.44% of n-3 PUFA was obtained after molecular distillation at lower temperature (140 °C). In addition, the EEs produced during ethanolysis had a FA composition similar to that of the original EEs, making them feasible for cyclic utilization. This was the first study reporting removal of partial glycerides by ethanolysis. Through ethanolysis, a higher purity product could be easily obtained at a relatively low temperature compared with the conventional high-temperature molecular distillation.


  • Synthesis of DHA/EPA-rich phosphatidylcholine by immobilized phospholipase A1: effect of water addition and vacuum condition

    by Daoming Li, Xiaoli Qin, Weifei Wang, Zhigang Li, Bo Yang, Yonghua Wang

    DHA/EPA-rich phosphatidylcholine (PC) was successfully synthesized by immobilized phospholipase A1 (PLA1)-catalyzed transesterification of PC and DHA/EPA-rich ethyl esters in a solvent-free system. Effects of reaction temperature, water addition and substrate mass ratio on the incorporation of DHA/EPA were evaluated using response surface methods (RSM). Water addition had most significant effect on the incorporation. Reaction temperature and substrate mass ratio, however, had no significant effect on the incorporation. The maximal incorporation was 19.09 % (24 h) under the following conditions: temperature 55.7 °C, water addition 1.1 wt % and substrate mass ratio (ethyl esters/PC) 6.8:1. Furthermore, effects of water addition (from 0 to 1.25 wt %) on DHA/EPA incorporation and the composition of products were further investigated. The immobilized PLA1 was more active when water addition was above 0.5 wt %. By monitoring the reaction processes with different water addition, a possible reaction scheme was proposed for transesterification of PC with DHA/EPA-rich ethyl esters. In summary, PC and sn2-lysophosphatidylocholine (LPC) were predominant in the mixtures at early stages of reaction, whereas sn1-LPC and glycerophosphocholine (GPC) predominant at later stages. The vacuum employed after 24 h significantly increased the incorporation of DHA/EPA and the composition of PC, and the highest incorporation (30.31 %) of DHA/EPA was obtained at 72 h and the yield of PC was 47.2 %.


  • [Gene therapy using a dominant negative form of the protein phosphatase 2A catalytic subunit a driven by a hepatoma tissue-specific promoter achieves effective growth inhibition of hepatoma cells].

    by Dao-Ming Li, Wei Li, Min Tao, Kai Chen, Fei-Ran Gong, Ze-Kuan Xu, Zheng Chen

    To generate a gene delivery plasmid carrying the dominant negative form of the protein phosphatase 2A catalytic subunit a (DN-PP2Aca) driven by a hepatocellular carcinoma (HCC) tissue-specific promoter and investigate its ability to inhibit growth of cultured hepatoma cells. The gene delivery plasmid was constructed by PCR-amplifying DN-PP2Aca from wild-type PP2Aca using site-directed mutagenesis and then ligating the sequence-verified amplicon downstream of an alpha-fetoprotein enhancer and phosphoglycerate kinase promoter (AFpg) in the luciferase reporter vector pGL3-Basic. Following transfection into two AFP+ hepatoma cell lines (HepG2 and HepG3) and two AFP- hepatoma cell lines (SK-HEP-1 and L02), the transcriptional activity of the AFpg-driven DN-PP2Aca plasmid was tested using luciferase reporter gene assay and western blotting. The effect on cell growth was tested using MTT assay. Between group differences were assessed by t-test. The AFpg-driven DN-PP2Aca plasmid showed high transcriptional activity and protein expression in both HepG2 and Hep3B cells. At 72 h after transfection, the proliferation capacities were repressed by 42.65%+/-3.99% (P = 0.0002) and 39.87%+/-3.91% (P = 0.0002) in AFP+ HepG2 and Hep3B cells, respectively (vs. untransfected). In contrast, the plasmid was transcriptionally inactive in and had no effect on proliferation of AFP- cells. The AFpg-driven DN-PP2Aca plasmid exhibits selective cytotoxicity against AFP+ hepatoma cells, and may represent a useful gene therapy strategy to treat HCC.